Ovarian Toxicity from Sirolimus
Ovarian Toxicity from Sirolimus
About this item
Full title
Author / Creator
Publisher
United States: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
United States: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
Low-dose oral sirolimus appears to increase the risk of menstrual-cycle disturbances and ovarian cysts. Monitoring patients for sirolimus-associated ovarian toxicity may be considered.
To the Editor:
Sirolimus prevents rejection of renal allografts by blocking the mammalian target of rapamycin (mTOR), a signaling pathway known to regulate ova...
Alternative Titles
Full title
Ovarian Toxicity from Sirolimus
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_928437254
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_928437254
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMc1113145
